Recombinant collagen type vii, preparation method therefor and the use thereof
Patent Information
- Application Number
- PCT/CN2025/080137
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-03-05
- Filing Date
- 2025-03-03
- Publication Date
- 2025-10-02
AI Technical Summary
In the existing technology, the expression level of type VII collagen is low and its stability is poor, making it difficult to achieve large-scale production. In addition, the existing expression system is expensive and the purification steps are complicated, making it impossible to industrialize.
The eukaryotic Pichia pastoris expression system was used to construct a recombinant vector to efficiently express type VII collagen in Pichia pastoris. Yeast's own enzyme cleavage technology was used to avoid in vitro enzyme cleavage, increase expression levels, and simplify the purification process.
The efficient secretory expression of type VII collagen was achieved, and the difficulty of purification was reduced. The obtained recombinant protein is similar to the natural protein, has good biological functions and tissue absorption effects, and is suitable for use in the fields of drugs, medical devices, biomaterials, etc.
Smart Images

Figure CN2025080137_02102025_PF_FP_ABST